Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Generic Drug Economic Experts(?)

Council Members in this Study Group: 586

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

What is a GLG Leader?
William Kelley
Principal
GordonBearcatResearch.com

Bill Kelley is the Principal of GordonBearcatResearch.com. Mr. Kelley specializes in several retailing businesses which are specified on his website. He works with investors, private equity specialists, and other consultants. Mr. Kelley was the Chairman, President and CEO of Consolidated Stores Corp....

Taral Patel, MD, Oncologist, Mid Ohio Oncology Hematology Inc.Taral Patel, MD
Oncologist
Mid Ohio Oncology Hematology Inc.

Taral Patel, MD, is an Oncologist in private practice with Mid Ohio Oncology-Hematology, Inc. He treats patients with both cancer and blood disorders. Dr. Patel has been a principal investigator for multiple clinical trials in colon cancer, lung cancer, lymphoma, and growth factor. He has been on the...

Dea Belazi, PharmD, MPH, PAHM, Pharmacy Consultant, Dea Belazi, PharmD, MPH, PAHMDea Belazi, PharmD, MPH, PAHM
Pharmacy Consultant
Dea Belazi, PharmD, MPH, PAHM

Dea Belazi, PharmD, MPH, PAHM, is currently a consultant working with health plans and pharmaceutical companies. He was previously the Senior Director of Pharmacy Services for Independence Blue Cross, a large commercial and Medicare health plan in Pennsylvania. Prior to this position, he was the Associate...

Eric Gruff, PhD MBA, Principal, E4 ConsultingEric Gruff, PhD MBA
Principal
E4 Consulting

Eric Gruff, PhD, MBA, BS, is the Founder of E4 Consulting, which specializes in pharmaceutical development, regulatory affairs, and project and portfolio management. Dr. Gruff has over 16 years of experience in the pharmaceutical and biotech sector, including leadership roles at Pfizer, Agouron Pharmaceuticals,...

Bilyana Savic
President
Insurance Insights

Bilyana Savic is the President of Insurance Insights. She is a consultant to insurance companies and insurance brokerage firms, specializing in the health insurance product categories of major medical, life, long term care, Medicare supplement, disability, accident and specified disease, but also with...

Hany Salama, Director, Global Manufacturing and Pharmaceutical , Barrier TherapeuticsHany Salama
Director, Global Manufacturing and Pharmaceutical
Barrier Therapeutics

Hany Salama, ME, MBA, CPM, is the Director of Global Manufacturing and Pharmaceuticals at Barrier Therapeutics, Inc., New Jersey. He has global responsibilities for commercial planning, supply chain, and manufacturing operations for all clinical and marketed products. Mr. Salama is also responsible...

Robert Dondes
Independent Consultant
Robert Dondes, Consultant

Robert Dondes is an Independent Consultant based in the mid-Atlantic United States, with headquarters in Maryland. His private practice focuses on managed care, health insurance, strategic analysis, and operational improvement. Mr. Dondes is affiliated with the consulting division of the Pennsylvania...

Adam Fein, PhD, Founder & President, Pembroke Consulting Inc Adam Fein, PhD
Founder & President
Pembroke Consulting Inc

Adam Fein, PhD, is the Founder and President of Pembroke Consulting, Inc., a Philadelphia-based management advisory and business research firm. Dr. Fein is one of the country’s foremost experts on pharmacy economics and the pharmaceutical supply chain. He provides strategic advisory services to a diverse...

View all GLG Leaders in this Study Group

GLG NewsSMAnalyses by this Study Group's Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Yes - please stop the cycle of 70 deaths then pull the drug! | 07-03-2008
Author: GLG Expert Contributor

Drugs are released to the market without adequate study, then, after around 70 to 100 patient deaths due to the drug are reported, the drug is pulled from the market.  Getting in front of this "problem" would improve the safety of our drug supply.

A Faulty Track-and-Trace Cost Model for Pharmacies | 07-02-2008
Author: Adam Fein, PhD, Founder & President, Pembroke Consulting Inc

A new report from Accenture attempts to assess the financial costs of implementing a serialized track-and-trace system for the U.S. pharmacy supply chain. But even if we assume that Accenture did a credible and impartial job building their pharmacy cost models, the estimates in this report reflect an...

Rite-Aid: From Worse to Awful | 07-02-2008
Analysis of: Acquired Stores Weigh on Rite Aid | online.wsj.com
Author: Adam Fein, PhD, Founder & President, Pembroke Consulting Inc

Perpetual also-ran Rite-Aid (RAD) reported another quarter of weak results. When Rite-Aid Brooks/Eckerd came together in August 2006, the deal seemed to make sense given the marketplace dynamics although none of the companies were as well run as CVS or Walgreens. However, the company’s ongoing struggles...

Walgreens’ $4.33 Surrender to Wal-Mart | 07-02-2008
Analysis of: Walgreens prescribes more club card use | www.suntimes.com
Author: Adam Fein, PhD, Founder & President, Pembroke Consulting Inc

Walgreens (WAG) has begun touting its Walgreens Prescription Savings Club, which offers a 3-month supply of over 400 generics for $12.99 (plus an annual membership fee). Walgreens latest move suggests that the low-priced generic wave is having a bigger effect that many people (including me) expected....

Looks like the Britons don't care anyway... | 06-30-2008
Author: GLG Expert Contributor

Drug company (Roche) retaliates against an agency that speaks the truth about their chemical - that it's cost is not worth the minimal benefit.  This will become more common as time goes on, even here in the bastion of capitalism.

View All GLG News by members of this Study Group

GLG InstituteSM Seminars with this Study Group's Leaders(?)

 

Recent Seminars

GLGi: Managed Care Formulary
New York, 07-30-2007

Most Common Company Types:

  • Pharmaceuticals Manufacturer
  • Academic Medical Center/Hospital or Clinic
  • Consultancy, Pharma-Focused
  • Pharmacy or Drug Store, Chain
  • Office Based Private Practice or Clinic
  • Consultancy, Healthcare-Focused
  • Pharmacy or Drug Store, Independent/Local
  • Individual/Small Consultancy

Most Common Job Types:

  • Director
  • President
  • Pharmacist - RPh/PharmD
  • Owner
  • Physician - Attending Physician
  • Chief Executive Officer
  • Principal
  • Consultant
  • Manager
  • Physician - Director

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics